As VEGFA is known to promote angiogenesis during tumor progression in a variety of cancers, we next assessed whether inhibition of VEGFA also blocked angiogenesis in ERMS in vivo. The gene discussed is VEGFA; the disease is embryonal rhabdomyosarcoma.